{
  "query": "eli lilly",
  "company_name": "eli lilly",
  "ticker": null,
  "articles_analyzed": 48,
  "articles_total": 48,
  "total_weight": 33.2236,
  "weighted_scores": {
    "positive": 9.7714,
    "negative": 20.5175,
    "neutral": 0.0
  },
  "normalized_scores": {
    "positive": 0.2941,
    "negative": 0.6176,
    "neutral": 0.0
  },
  "final_label": "negative",
  "final_confidence": 0.6176,
  "article_details": [
    {
      "title": "Dow, S&P 500 end lower; Eli Lilly shares fall after drug data",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.007518396712839603,
        "negative": 0.9851248264312744,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0073,
        "negative": 0.9589,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly's Share Price Sheds Some Weight: This Doesn't Mean To Pile In",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.03396853432059288,
        "negative": 0.9320898056030273,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0331,
        "negative": 0.9073,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly’s weight-loss pill didn’t work so well, and the stock is plunging",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.005922757089138031,
        "negative": 0.9904716610908508,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0058,
        "negative": 0.9641,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly Q2 Earnings: Ignore Oral Weight Loss Bombshell, This Is A Buy The Dip Moment",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.8777568340301514,
        "negative": 0.08507554233074188,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.8544,
        "negative": 0.0828,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly and Company 2025 Q2 - Results - Earnings Call Presentation",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.3430298864841461,
        "negative": 0.4028591513633728,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.3339,
        "negative": 0.3921,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly Shares Slide as Weight-Loss Pill Results Dent Enthusiasm",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.01640259101986885,
        "negative": 0.9727173447608948,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.016,
        "negative": 0.9468,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.7901830077171326,
        "negative": 0.0992354229092598,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.7692,
        "negative": 0.0966,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly Stock Dives Drops After Earnings Beat. Here’s Why.",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.01223311573266983,
        "negative": 0.9801896810531616,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0119,
        "negative": 0.9541,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly second quarter earnings beat on strong GLP-1 sales, but stock dives on GLP-1 pill trial results",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.24926133453845978,
        "negative": 0.5757529735565186,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.2426,
        "negative": 0.5604,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly’s Weight Loss Pill Doesn’t Work as Well as Investors Hoped. The Obesity Trade Is Wavering Again.",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.013586790300905704,
        "negative": 0.97798091173172,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0132,
        "negative": 0.952,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly: targets raised for 2025",
      "final_weight": 0.9734,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.6353891491889954,
        "negative": 0.2475571632385254,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.6185,
        "negative": 0.241,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly Reports Earnings, and Maybe Weight-Loss Pill Data, on Thursday",
      "final_weight": 0.9379,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.314860075712204,
        "negative": 0.40063777565956116,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.2953,
        "negative": 0.3758,
        "neutral": 0.0
      }
    },
    {
      "title": "RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program",
      "final_weight": 0.9379,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.03827161714434624,
        "negative": 0.9188600182533264,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0359,
        "negative": 0.8618,
        "neutral": 0.0
      }
    },
    {
      "title": "Is Wall Street Bullish or Bearish on Eli Lilly Stock?",
      "final_weight": 0.9379,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.3076005280017853,
        "negative": 0.36333486437797546,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.2885,
        "negative": 0.3408,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly Earnings: What To Look For From LLY",
      "final_weight": 0.9379,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.3296709358692169,
        "negative": 0.3861331641674042,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.3092,
        "negative": 0.3622,
        "neutral": 0.0
      }
    },
    {
      "title": "Inspire Medical Systems Crashes 32% As Eli Lilly's GLP-1 Weighs On Guidance",
      "final_weight": 0.8946,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.015935268253087997,
        "negative": 0.9680755734443665,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0143,
        "negative": 0.866,
        "neutral": 0.0
      }
    },
    {
      "title": "Evers announces $100 million tax credits deal with Eli Lilly for Kenosha County development",
      "final_weight": 0.8946,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.5887019634246826,
        "negative": 0.19858694076538086,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.5267,
        "negative": 0.1777,
        "neutral": 0.0
      }
    },
    {
      "title": "Health Care Down After Eli Lilly Earnings -- Health Care Roundup",
      "final_weight": 0.8612,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.014864848926663399,
        "negative": 0.9723880290985107,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0128,
        "negative": 0.8374,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly Dives 14% On A Shocking Obesity Setback, Sending Its Rivals Flying",
      "final_weight": 0.8612,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.012965686619281769,
        "negative": 0.9773887991905212,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0112,
        "negative": 0.8417,
        "neutral": 0.0
      }
    },
    {
      "title": "Stock Market Today: Dow Futures Rise On Trump Tariff News; Apple, Nvidia Rally, Eli Lilly Plunges (Live Coverage)",
      "final_weight": 0.8612,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.02776249311864376,
        "negative": 0.9538871049880981,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0239,
        "negative": 0.8215,
        "neutral": 0.0
      }
    },
    {
      "title": "Novo Nordisk shares jump as Eli Lilly obesity pill disappoints",
      "final_weight": 0.8612,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.07465825229883194,
        "negative": 0.867985188961029,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0643,
        "negative": 0.7475,
        "neutral": 0.0
      }
    },
    {
      "title": "Danish drugmakers jump as Eli Lilly's weight-loss pill data disappoints",
      "final_weight": 0.8612,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.11299453675746918,
        "negative": 0.8204024434089661,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0973,
        "negative": 0.7065,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors",
      "final_weight": 0.8612,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.08836323767900467,
        "negative": 0.839116096496582,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0761,
        "negative": 0.7226,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly: The Worst May Be Already Over (Earnings Preview)",
      "final_weight": 0.8583,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.2612055540084839,
        "negative": 0.7084260582923889,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.2242,
        "negative": 0.608,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly stock drops after Trump unleashes 250% pharma tariff warning",
      "final_weight": 0.7294,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.008679582737386227,
        "negative": 0.9843959808349609,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0063,
        "negative": 0.718,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Reports Results From SURPASS-CVOT Study: Mounjaro's Impact Analyzed",
      "final_weight": 0.6684,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.2742502689361572,
        "negative": 0.5064436793327332,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.1833,
        "negative": 0.3385,
        "neutral": 0.0
      }
    },
    {
      "title": "Trim Your AI Stocks And Buy Eli Lilly",
      "final_weight": 0.6684,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.9787759184837341,
        "negative": 0.015441392548382282,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.6542,
        "negative": 0.0103,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly: The Best Growth Prospects Come At A Price",
      "final_weight": 0.6684,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.10086312144994736,
        "negative": 0.8356510996818542,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0674,
        "negative": 0.5585,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly’s Mounjaro shows cardiovascular gains, but analysts underwhelmed",
      "final_weight": 0.6684,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.10553284734487534,
        "negative": 0.7424306273460388,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0705,
        "negative": 0.4962,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly and Company (LLY): We Sold Some Lilly, Says Jim Cramer",
      "final_weight": 0.6058,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.05110607296228409,
        "negative": 0.8969957828521729,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.031,
        "negative": 0.5434,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Reveals Promising Diabetes and Alzheimer's Trials Results",
      "final_weight": 0.6058,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.6209300756454468,
        "negative": 0.20876432955265045,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.3762,
        "negative": 0.1265,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly and Company (LLY): Jim Cramer’s “Bullish” On News Of Tariffs",
      "final_weight": 0.5435,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.9617956280708313,
        "negative": 0.023022722452878952,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.5227,
        "negative": 0.0125,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Unveils Alzheimer's And CLL Trial Results With New LTZ Collaboration",
      "final_weight": 0.5435,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.491573303937912,
        "negative": 0.28575393557548523,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.2672,
        "negative": 0.1553,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Declines More Than Market: Some Information for Investors",
      "final_weight": 0.4826,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.028294425457715988,
        "negative": 0.9498450756072998,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0137,
        "negative": 0.4584,
        "neutral": 0.0
      }
    },
    {
      "title": "Why Eli Lilly (LLY) Stock Is Falling Today",
      "final_weight": 0.4826,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.017881274223327637,
        "negative": 0.9666091203689575,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0086,
        "negative": 0.4665,
        "neutral": 0.0
      }
    },
    {
      "title": "Nvidia's TSMC order, Eli Lilly & Novo Nordisk sink, JPMorgan & Apple card",
      "final_weight": 0.4826,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.009266925044357777,
        "negative": 0.9845992922782898,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0045,
        "negative": 0.4752,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Stock Set to Gain on Early Alzheimer’s Trial Results, Says BMO Capital",
      "final_weight": 0.4826,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.9150896072387695,
        "negative": 0.04815557971596718,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.4416,
        "negative": 0.0232,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly and Company (LLY) Announces New Phase 3 Trial Results for Orforglipron",
      "final_weight": 0.4826,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.4243444502353668,
        "negative": 0.3394825756549835,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.2048,
        "negative": 0.1638,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly stock rises, Novo Nordisk shares jump on potential Medicare coverage",
      "final_weight": 0.4629,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.9839644432067871,
        "negative": 0.008480408228933811,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.4555,
        "negative": 0.0039,
        "neutral": 0.0
      }
    },
    {
      "title": "Analyst Highlights ‘Game Changer’ Catalyst for Eli Lilly (LLY)",
      "final_weight": 0.4242,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.8476555347442627,
        "negative": 0.11032219976186752,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.3596,
        "negative": 0.0468,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Gets Price Target Boost as Analysts See Strong Mounjaro, Zepbound Sales",
      "final_weight": 0.4242,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.9004355669021606,
        "negative": 0.06286919862031937,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.382,
        "negative": 0.0267,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly’s stock drops as Trump targets 17 drug makers with letters on their pricing",
      "final_weight": 0.4028,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.00463995523750782,
        "negative": 0.9919862747192383,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0019,
        "negative": 0.3996,
        "neutral": 0.0
      }
    },
    {
      "title": "Morgan Stanley Remains Bullish on Eli Lilly (LLY)",
      "final_weight": 0.3321,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.9752985239028931,
        "negative": 0.01593366451561451,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.3239,
        "negative": 0.0053,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Announces Positive Results For Jaypirca In Phase 3 Trial",
      "final_weight": 0.2957,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.8413265943527222,
        "negative": 0.07962992042303085,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.2488,
        "negative": 0.0235,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth",
      "final_weight": 0.2275,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.576570451259613,
        "negative": 0.25483059883117676,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.1312,
        "negative": 0.058,
        "neutral": 0.0
      }
    },
    {
      "title": "Insights Into Lilly (LLY) Q2: Wall Street Projections for Key Metrics",
      "final_weight": 0.1191,
      "input_source": "content-only",
      "raw_scores": {
        "positive": 0.3560388386249542,
        "negative": 0.3994007110595703,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0424,
        "negative": 0.0476,
        "neutral": 0.0
      }
    },
    {
      "title": "How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings",
      "final_weight": 0.081,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.8250607848167419,
        "negative": 0.10190069675445557,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.0668,
        "negative": 0.0083,
        "neutral": 0.0
      }
    },
    {
      "title": "Eli Lilly and Company (LLY) Q2 2025 Earnings Call Transcript",
      "final_weight": 0.0658,
      "input_source": "headline+content",
      "raw_scores": {
        "positive": 0.33384761214256287,
        "negative": 0.3906712234020233,
        "neutral": 0.0
      },
      "weighted_scores": {
        "positive": 0.022,
        "negative": 0.0257,
        "neutral": 0.0
      }
    }
  ]
}